Table 1.
Group A (VISPO oral) N = 18 | Group B (Placebo oral) N = 19 | Group C (VISPO Topical) N = 18 | Group D (Placebo Topical) N = 18 | p-value (A vs B) | p-value (C vs D) | ||
---|---|---|---|---|---|---|---|
Sex | Male, n (%) | 14 (70) | 14 (70) | 16 (80) | 16 (80) | 1.000# | 1.000# |
Female, n (%) | 6 (30) | 6 (30) | 4 (20) | 4 (20) | |||
Age (y) | 35.10±6.03 | 36.45±6.01 | 34.05±7.07 | 35.85±6.28 | 0.483‡ | 0.399‡ | |
Height (cm) | 166.40±10.19 | 165.55±8.12 | 169.05±8.11 | 170.60±8.71 | 0.708‡ | 0.134‡ | |
Weight (kg) | 67.06±9.90 | 68.23±9.65 | 68.19±10.91 | 73.31±10.22 | 0.772‡ | 0.564‡ | |
BMI (kg/m2) | 24.20±2.67 | 24.82±2.48 | 23.76±2.74 | 25.13±2.38 | 0.452‡ | 0.101‡ |
Notes: The values are presented as the mean ± standard deviation. #Chi-square test; ‡Unpaired t-test.